ImmunityBio, Inc. IBRX

https://stocks.apple.com/Ai-4OWdrUSxa_3mI-mIcUIg

And we were down for the week

We will never see the explosive upside 🚀 without CNBC FoxB talking about Anktiva and the other clinical trials and interviewing Dr PSS. That's the facts like them or not.

IBRX needs EMA to quickly grant the same approval ASAP.

Next we need ImmunityBio to file for lung cancer and Glioblastoma approvals with the FDA and EMA simultaneously. Get Saudi UAE and Turkey to start treating lung and glioblastoma and show the world the incredible results.

I dropped $885,000 on paper in a week and it sucks and makes me very 😡😡😡

No MSM coverage and no MSM interview so Wall Street can stay in control...........

DO YOU ALL GET IT.... ??????UNDERSTAND...??? ???

Covid and the mRNA jabs plus the failed protocols in the hospitals that were the same all of the country with no effort to adjust and change them, woke me up to the corruption of America and the World.

Watching the MSM suppress the news and how they boycott ImmunityBio confirms how corrupt and evil the world and America is. The FDA holding Anktiva back for almost 2 years for use for all of bladder only has one explanation protecting Keytruda and Merck's sales.

When IBRX finally plays out I am done buying individual stocks.

Stop lending your shares to the evils and stop selling any shares if you want to destroy them.

Wow I sure now how to pick the stock that Wall Street punishes because Big Pharma wants to suppress it. Why can't IBRX be the stock that flys up on incredible news and a bunch of positive on going clinical trials? Oh MSM won't cover the news or do a story on them and their science. 😡😡😡😡

WTF THE TRADING IN IBRX needs to be SEC INVESTIGATED

Companies like IBRX should trade on the future of it science and additional
fDA approved uses and expanded rapid use. They shouldn't be trading on current sales and profit loss.

Another BS start to the day who is selling? Why would anyone sell a single share with full FDA for bladder and with all the positives coming.